In the Emergency Department the patient was unresponsive and so was intubated for airway protection.
The patient's blood pressure decreased and he was started on intravenous fluids and Dopamine drip.
The patient was given 2 mg of Vitamin K in the Emergency Room, Ceftriaxone, and admitted.
The patient was then cultured and given a dose of Vancomycin as well.
The patient was given intravenous fluids but it is unclear the amounts that were given.
Chronic obstructive pulmonary disease on home oxygen, 1 to 2 liters per minute, history of multiple prior intubations; 2.
Legally blind, secondary to moonshine ingestion; 9.
MEDICATIONS ON ADMISSION:  Medications as an outpatient include - 1.
Digoxin 0.25 every day except Tuesday and Friday when he receives 0.5; 2.
Lipitor 40 mg p.o.
Lasix 20 mg p.o.
Bisoprolol 5 mg p.o.
Combivent 2 puffs q.i.d.
Flovent 110 mcg 4 puffs b.i.d.
Albuterol metered dose inhaler prn.
Neurological:  Patient intubated and sedated, responds to pain.
Urinalysis, large blood, trace ketones, 12 to 50 red blood cells, no white blood cells or bacteria.
Pulmonary - The patient was transferred from an outside hospital for evaluation for inferior vena cava filter placement for suspected pulmonary embolism in the setting of Coumadin taken for atrial flutter.
The patient initially started on therapeutic Lovenox and Coumadin was held for supratherapeutic INR.
This was changed to pressor support which was gradually weaned and the patient was extubated on [**2184-8-16**].
Following extubation, the patient was placed on a Venturi mask with goal SPO2 of 88 to 93.
The patient was also continued on intravenous Solu-Medrol for suspected chronic obstructive pulmonary disease exacerbation.
As the congestive heart failure may be a component in the patient's respiratory failure, the patient's Lasix was restarted and gentle diuresis was performed.
The patient received urine cultures, blood cultures and sputum cultures on admission and was started on broad spectrum antibiotics, Vancomycin and Zosyn.
Vancomycin and Zosyn were continued for a total of a seven day course at which time they were discontinued as the patient's white blood cell count began to normalize and the patient remained afebrile.
The patient was titrated off of Dopamine and Levophed was started.
Vasopressin was added as needed.
In order to achieve increased inotrope a trial of Dobutamine was begun, however, the patient did not tolerate this with elevated heartrate in the 150s to 160s.
The patient was started again on Levophed and Vasopressin which were gradually weaned off to discontinue on [**2184-8-14**].
He was stated on a Nitroglycerin drip on the evening of [**2184-8-16**] which was slowly weaned.
The patient was restarted on Digoxin and Lipitor at home doses and restarted on standing Lasix with good urine output.
The patient was also started on Captopril which was titrated up to 25 mg p.o.
The patient's Nitroglycerin drip was discontinued [**2184-8-17**].
Hematology - The patient's Coumadin was held following admission and initially the patient received therapeutic doses of Lovenox for suspected pulmonary embolism.
When CTA was negative for pulmonary embolism, the patient was changed to Lovenox at deep vein thrombosis prophylactic doses.
The patient will receive the first dose of Coumadin on the day of discharge.
INR levels will need to be monitored and the Coumadin doses adjusted as needed for  a goal INR of 2 to 3.
DISCHARGE MEDICATIONS: Captopril 25 mg p.o.
Bisoprolol 5 mg p.o.
Aspirin 325 mg p.o.
2 hour prn Albuterol nebulizers q.
2 hour prn Coumadin 5 mg p.o.
Solu-Medrol 80 mg intravenously q.d.
with plan for a slow taper as an outpatient decreasing by 10 mg q.d.
4-6 hours prn Ativan 2 mg intravenously q.
4 hours prn Flovent 110 mcg 4 puffs inhaled b.i.d.
Atorvastatin 40 mg p.o.
Digoxin 0.25 mg p.o.
Famotidine 20 mg intravenously q.
12 hours  FOLLOW UP:  The patient is to follow up with primary care physician within one week of discharge from acute rehabilitation facility.
